PT Pyridam Farma Tbk (IDX:PYFA)

Market Cap	4.38T +96.0%
Revenue (ttm)	2.76T +43.7%
Net Income	-379.67B
EPS	-33.79
Shares Out	11.24B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	223,841,000
Average Volume	60,787,880
Open	416.00
Previous Close	412.00
Day's Range	380.00 - 446.00
52-Week Range	199.00 - 700.00
Beta	0.82
RSI	59.51
Earnings Date	May 13, 2026

About PT Pyridam Farma Tbk

PT Pyridam Farma Tbk engages in the pharmaceutical business in Australia, Indonesia, Philippines, Singapore, and India. The company operates through two segments, Pharmaceutical Products, Esthetic and Toll Manufacturing Services; and Medical Equipment segments. It supplies medical instruments and equipment, including clinical waste, collection swab, collection tube, innerbox DCA, KF94 mask, parafilm, PCR - extraction kit and extractor machine, speciment bag, sterile container, PCR machine- Gentier 48, and tube stopper. The company also provides...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1976
• Employees: 2,341
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: PYFA

Financial Performance

In 2025, PT Pyridam Farma Tbk's revenue was 2.76 trillion, an increase of 43.71% compared to the previous year's 1.92 trillion. Losses were -379.67 billion, 15.0% more than in 2024.